InBody Overview
- Year Founded
-
1996
- Status
-
Public
- Employees
-
394
- Stock Symbol
-
041830
- Investments
-
5
- Share Price
-
$29.08
- (As of Friday Closing)
InBody General Information
Description
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.
Contact Information
Website
inbody.comCorporate Office
- InBogy Building, 625, Eonju-ro
- Gangnam-gu
- Seoul, 06106
- South Korea
Corporate Office
- InBogy Building, 625, Eonju-ro
- Gangnam-gu
- Seoul, 06106
- South Korea
InBody Stock Performance
As of 13-Nov-2026, InBody’s stock price is $29.08. Its current market cap is $388M with 13.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $29.08 | $29.66 | $18.03 - $51.65 | $388M | 13.4M | 84.4K | $2.44 |
InBody Financials Summary
As of 30-Jun-2026, InBody has a trailing 12-month revenue of $182M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 411,350 | 215,134 | 134,103 | 188,414 |
| Revenue | 181,838 | 164,389 | 149,853 | 130,293 |
| EBITDA | 46,248 | 31,409 | 35,139 | 36,454 |
| Net Income | 32,073 | 21,525 | 24,290 | 28,087 |
| Total Assets | 251,736 | 250,736 | 207,619 | 212,975 |
| Total Debt | 5,192 | 7,183 | 5,715 | 4,718 |
InBody Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InBody Comparisons
Industry
Financing
Details
InBody Competitors (2)
One of InBody’s 2 competitors is seca (Monitoring Equipment), a Corporation company based in Hamburg, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| seca (Monitoring Equipment) | Corporation | Hamburg, Germany | ||||
| Fit3D | Venture Capital-Backed | Rocklin, CA |
InBody Patents
InBody Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026058991-A1 | Electronic device for determining body composition of user and operation method thereof | Pending | 12-Sep-2024 | ||
| WO-2025230165-A1 | Electronic device for determining differences in body composition of body parts and operation method thereof | Pending | 29-Apr-2024 | ||
| WO-2025211495-A1 | Height measuring device | Pending | 04-Apr-2024 | ||
| AU-2025225369-A1 | Electronic device for determining dry weight range and operating method thereof | Pending | 20-Feb-2024 | ||
| WO-2025178351-A1 | Electronic device for determining dry weight range and operating method thereof | Pending | 20-Feb-2024 |
InBody Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
InBody Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
InBody Investments (5)
InBody’s most recent deal was a Later Stage VC with MyBenefit for . The deal was made on 19-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| MyBenefit | 19-Oct-2026 | Later Stage VC | Other Healthcare Technology Systems | ||
| B-Innovation | 03-Aug-2026 | Later Stage VC | Other Healthcare Technology Systems | ||
| Bluepoint | 22-Dec-2025 | Later Stage VC | Private Equity | ||
| Common Computer | 28-Jul-2023 | Later Stage VC | Systems and Information Management | ||
| Changseon Kim (Portfolio of Land and Buildings in Seoul, South Korea) | 24-May-2018 | Corporate Asset Purchase | Buildings and Property |
InBody ESG
Risk Overview
Risk Rating
Updated September, 30, 2025
31.03 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,999
Rank
Percentile
Healthcare
Industry
of 665
Rank
Percentile
Medical Devices
Subindustry
of 235
Rank
Percentile
InBody FAQs
-
When was InBody founded?
InBody was founded in 1996.
-
Where is InBody headquartered?
InBody is headquartered in Seoul, South Korea.
-
What is the size of InBody?
InBody has 394 total employees.
-
What industry is InBody in?
InBody’s primary industry is Monitoring Equipment.
-
Is InBody a private or public company?
InBody is a Public company.
-
What is InBody’s stock symbol?
The ticker symbol for InBody is 041830.
-
What is the current stock price of InBody?
As of 13-Nov-2026 the stock price of InBody is $29.08.
-
What is the current market cap of InBody?
The current market capitalization of InBody is $388M.
-
What is InBody’s current revenue?
The trailing twelve month revenue for InBody is $182M.
-
Who are InBody’s competitors?
seca (Monitoring Equipment) and Fit3D are competitors of InBody.
-
What is InBody’s annual earnings per share (EPS)?
InBody’s EPS for 12 months was $2.44.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
